Spine - 2026-10-15 - Journal Article
Should We Re-Instrument the Originally Fused Level in ACDF Revision for Adjacent Segment Disease?: A Quality Outcomes Database Study.
Bathon JF, Zakieh O, Davidson C, Hymel AM, Pennings JS, Young MW, Bowers MF, Abtahi AM, Gardocki RJ, Lugo-Pico JG, Zuckerman SL, Stephens BF
Topics
Key Takeaway
Reinstrumentation of the original ACDF level during revision for ASD increased operative time by 30 minutes and blood loss by ~20 mL but produced no difference in NDI, mJOA, or reoperation rates at 24 months compared to single-level adjacent segment fusion alone.
Summary Depth
Choose how much analysis to show on this article page.
Summary
This QOD registry study compared outcomes of revision ACDF with reinstrumentation of the original fusion level (25%, n≈192) versus single-level adjacent segment fusion alone (75%, n≈575) in patients with ASD. Reinstrumentation produced significantly greater blood loss (60.7 vs. 40.9 mL), operative time (123.8 vs. 93.8 min), and LOS (1.63 vs. 1.30 days). No between-group differences were detected in NRS neck/arm pain, NDI, EQ-5D, mJOA at 3, 12, or 24 months, or reoperation rates at 12 months (5.7% vs. 4.5%).
Key Limitation
Follow-up is limited to 24 months, which is insufficient to detect differences in construct failure, adjacent segment progression at a third level, or long-term reoperation rates that may favor reinstrumentation's biomechanical rationale.
Original Abstract
STUDY DESIGN
Retrospective cohort.
OBJECTIVE
To investigate differences in perioperative variables, patient-reported outcomes measures (PROMs), and reoperation rates between revision involving reinstrumentation of the originally fused level versus fusion of the adjacent segment alone in revision ACDF patients.
SUMMARY OF BACKGROUND DATA
Adjacent segment disease (ASD) continues to be a significant issue for patients undergoing anterior cervical discectomy and fusion (ACDF) surgery. Reinstrumenting the originally fused segment provides greater biomechanical stability. However, there remains a paucity of research investigating the differences in outcomes between patients undergoing reinstrumentation of the originally fused level versus only the adjacent segment level.
METHODS
Patients who underwent single-level, adjacent segment revision ACDF were identified from the Quality Outcome Database. The primary exposure was reinstrumentation of the original segment. Patient characteristics were compared. Outcomes were perioperative variables, 3-month and 12-month reoperation, and 3-month, 12-month, and 24-month PROMs, including numeric rating scale for neck and arm pain, neck disability index, EuroQol 5 Dimensions, and modified Japanese Orthopaedic Association scores. Multivariable regression models were fitted for each outcome.
RESULTS
Of the 767 patients undergoing revision ACDF, 25.0% had reinstrumentation. On analysis, patients with reinstrumentation had greater blood loss (60.7±11.6 vs. 40.9±10.8 mL, P < 0.001), operative time (123.8±8.0 vs. 93.8±7.4 mins, P < 0.001), and hospital length of stay (1.63±0.35 vs. 1.30±0.26 d, P = 0.004) than patients with single-level fusion alone. There was no difference in neck and arm pain, NDI, and mJOA PROMs at 3-months, 12-months, and 24-months between groups ( P > 0.05). Further, there was no difference in reoperation rates at 3-months (4.3% vs. 3.2%, P = 0.154) and 12-months (5.7% vs. 4.5%, P = 0.194).
CONCLUSIONS
Given comparable PROMs and reoperation rates, when clinically feasible, surgeons may consider avoiding reinstrumentation of the original ACDF fusion, opting for a more conservative single-level revision to minimize the negative risks/complications associated with increased perioperative blood loss, operative time, and length of stay.